OOIR: Observatory of International Research

Papers

(The H4-Index of European Journal of Internal Medicine is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis	357
Incidence of acute pulmonary embolism in COVID-19 patients: Systematic review and meta-analysis.	107
SARS-CoV-2 vaccines: Lights and shadows	97
Mobile health technology-supported atrial fibrillation screening and integrated care: A report from the mAFA-II trial Long-term Extension Cohort	93
Uric acid in metabolic syndrome: Does uric acid have a definitive role?	85
Low serum albumin: A neglected predictor in patients with cardiovascular disease	85
Optimizing antibiotic therapies to reduce the risk of bacterial resistance	75
Mechanisms of weight regain.	66
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study	65
Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study	60
Anakinra for patients with COVID-19: a meta-analysis of non-randomized cohort studies.	60
The 2020 International Society of Hypertension global hypertension practice guidelines - key messages and clinical considerations	55
Drug-induced liver injury: Pathogenesis, epidemiology, clinical features, and practical management	54
SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: Persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma donors	52
Prognostic impact of coronary microvascular dysfunction in patients with myocardial infarction with non-obstructive coronary arteries	51
Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series	50
The Brain-Gut-Microbiotal Axis: A framework for understanding functional GI illness and their therapeutic interventions	48
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection: One year later	46
“Is medical cannabis safe for my patients?” A practical review of cannabis safety considerations	43
Beyond the 2020 guidelines on atrial fibrillation of the European society of cardiology	41
Epidemiology of portal vein thrombosis in liver cirrhosis: A systematic review and meta-analysis	40
Device-detected atrial high rate episodes and the risk of stroke/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis	40
Blood pressure increase after Pfizer/BioNTech SARS-CoV-2 vaccine	39
Transthyretin amyloid cardiomyopathy: An uncharted territory awaiting discovery	38
How does SARS-CoV-2 targets the elderly patients? A review on potential mechanisms increasing disease severity	37

Consumer-led screening for atrial fibrillation using consumer-facing wearables, devices and apps: A survey of health care professionals by AF-SCREEN international collaboration	36
Gastroprotection in patients on antiplatelet and/or anticoagulant therapy: a position paper of National Association of Hospital Cardiologists (ANMCO) and the Italian Association of Hospital Gastroente	35
COVID-19, vaccines and deficiency of ACE2 and other angiotensinases. Closing the loop on the "Spike effect"	34
Comparing atrial fibrillation guidelines: Focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations	32
Pneumothorax/pneumomediastinum in non-intubated COVID-19 patients: Differences between first and second Italian pandemic wave	32
Physical activity in management of persons with obesity	31